Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: “Take what you find here and make it better and better.”
More than 140 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.
Bench to Breakthrough Supporters
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Revvity and BioLegend from Revvity provide health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. We are revolutionizing what’s possible in healthcare, with specialized focus areas in flow cytometry, translational multiomics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and more. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia, and governments. Follow us on Newsroom, LinkedIn, X, YouTube, Facebook, and Instagram.
